Primary Site >> Liver Cancer

Gene >> CD8A

  • 1991
  • 1992
  • 1997
  • 2011
  • 2012
  • 2016
  • 2017
  • 2018
Ref: Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
PMID: 1718596
Ref: [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
PMID: 1530292
Ref: Intrasplenic combination immunotherapy with OK-432 and interleukin-2 on liver metastasis of colorectal carcinoma in a mouse model.
PMID: 21533501
Ref: Simultaneous detection of T lymphocyte-related antigens (CD4/CD8, CD57, TCRbeta) with nuclei by fluorescence-based immunohistochemistry in paraffin-embedded human lymph node, liver cancer and stomach cancer.
PMID: 21791906
Ref: Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.
PMID: 22402625
Ref: Effect of immune suppression on metastasis in a patient with hepatocellular carcinoma metastasized to the colon and stomach: A case report.
PMID: 27168796
Ref: Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
PMID: 26669617
Ref: The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
PMID: 28432618
Ref: OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis.
PMID: 29632718
Ref: VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
PMID: 29720116
Ref: Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma.
PMID: 30264546